RYAN ARTHUR F
SEC insider (Form 3/4/5 filer). CIK 0001187443. Director at REGENERON PHARMACEUTICALS, INC. (REGN). 87 reported Form 4/5 transactions since Sep 2024; latest on Jul 2, 2026. Located in TARRYTOWN, NY.
Companies RYAN ARTHUR F has filed insider reports for
- REGENERON PHARMACEUTICALS, INC. (REGN): Director
RYAN ARTHUR F
CIK: 0001187443
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENERON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (87 total)
- Jul 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect200 shares at avg. $650.15$130K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect2 shares at avg. $710.87$1K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect5 shares at avg. $701.76$4K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect14 shares at avg. $705.56$10K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect4 shares at avg. $707.40$3K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect6 shares at avg. $709.45$4K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect24 shares at avg. $703.46$17K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect15 shares at avg. $702.46$11K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect15 shares at avg. $704.28$11K - May 1, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect7 shares at avg. $706.74$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 200 | $650.15 | $130,030 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 2 | $710.87 | $1,422 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 5 | $701.76 | $3,509 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 14 | $705.56 | $9,878 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 4 | $707.40 | $2,830 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 6 | $709.45 | $4,257 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 24 | $703.46 | $16,883 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 15 | $702.46 | $10,537 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 15 | $704.28 | $10,564 | Direct |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 7 | $706.74 | $4,947 | Direct |
1-10 of 87 transactions